These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 21550064)

  • 1. Occurrence of Residual Breast Tumors and Efficacy of MRI in their Detection after Vacuum-assisted Excisional Biopsy.
    Wei Q; Zheng Q; Gu Y; Teng R; Zhao W
    Curr Med Imaging; 2024; 20():e15734056289252. PubMed ID: 38494937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast MR imaging for the assessment of residual disease following initial surgery for breast cancer with positive margins.
    Krammer J; Price ER; Jochelson MS; Watson E; Murray MP; Schoenberg SO; Morris EA
    Eur Radiol; 2017 Nov; 27(11):4812-4818. PubMed ID: 28567547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging of the breast in evaluating residual diseases at lumpectomy site soon after excisional biopsy.
    Yang H; Liu H; Peng W; Hua Y
    J Comput Assist Tomogr; 2012; 36(2):196-9. PubMed ID: 22446359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI before reexcision surgery in patients with breast cancer.
    Lee JM; Orel SG; Czerniecki BJ; Solin LJ; Schnall MD
    AJR Am J Roentgenol; 2004 Feb; 182(2):473-80. PubMed ID: 14736685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postexcisional breast magnetic resonance imaging in patients with breast cancer: predictable findings of residual cancer.
    Kim JA; Son EJ; Kim EK; Kim MJ; Kwak JY; Jeong J
    J Comput Assist Tomogr; 2009; 33(6):940-5. PubMed ID: 19940664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim H; Lee J; Cheung JY
    AJR Am J Roentgenol; 2013 May; 200(5):1167-73. PubMed ID: 23617506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
    Smitt MC; Horst K
    Ann Surg Oncol; 2007 Mar; 14(3):1040-4. PubMed ID: 17203329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-time detection of breast cancer at the cellular level.
    Carver GE; Locknar SA; Weaver DL; Stein JL; Stein GS
    J Cell Physiol; 2019 May; 234(5):5413-5419. PubMed ID: 30362286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of breast MRI for evaluation of residual disease following excisional biopsy.
    Wilkinson J; Appleton CM; Margenthaler JA
    J Surg Res; 2011 Oct; 170(2):233-9. PubMed ID: 21550064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.